Brief: Biomed Lublin Signs Term Sheet With Apogepha On Financial Deal For Onko BCG Development

Synthaverse SA

17/02/2021 09:45

Feb 17 (Reuters) - Biomed Lublin Wytwornia Surowic i
Szczepionek SA  BML.WA :
    * SIGNS TERM SHEET WITH GERMANY-BASED APOGEPHA ARZNEIMITTEL
ON
CONDITIONS OF FINANCIAL DEAL
    * FINANCIAL DEAL REGARDS DEBT FINANCING IN RELATION TO
COMPANY'S
PROJECT, WHICH FOCUSES ON DEVELOPMENT OF MEDICAL PRODUCT ONKO
BCG
    * AFTER DEFINING THE POTENTIAL OF MARKETS AND COMPANY'S
PRODUCTION
CAPACITY FOR ONKO BCG, COMPANY DECIDES TO BUILD NEW PRODUCTION
FACILITY
    * ESTIMATED COST OF INVESTMENT AMOUNTS TO ABOUT 72.0 MILLION
ZLOTYS
    * PARTIES AGREED THAT APOGEPHA WILL LOAN EUR 4.5 MILLION FOR
REALISATION OF PROJECT

Source text for Eikon:  ID:nEM6RprYqa 
Further company coverage:  BML.WA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))